-+ 0.00%
-+ 0.00%
-+ 0.00%

Travere Therapeutics Director Timothy Coughlin sells 3,250 shares for $141,342.50

PUBT·05/19/2026 20:06:02
Listen to the news
Travere Therapeutics Director Timothy Coughlin sells 3,250 shares for $141,342.50
  • Travere Therapeutics director Timothy Coughlin sold 3,250 common shares on May 15, 2026 at USD 43.49.
  • His direct holding fell to 52,250 shares following the transaction.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Travere Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001376043-26-000005), on May 19, 2026, and is solely responsible for the information contained therein.